Status:
WITHDRAWN
A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The purpose of this study is to find out whether Contrast-Enhanced Mammography/CEM scans performed 2 minutes and 6 minutes after receiving Iohexol contrast dye can be used to identify the amount of re...
Eligibility Criteria
Inclusion
- Any women \>18 years of age at time of informed consent
- Diagnosed with breast cancer and schedule for NAT
Exclusion
- History of kidney disease, creatinine level \>1.3 or eGFR \<45.
- Known allergic reaction to gadolinium or iodinated contrast media.
- Contraindication to contrast-enhanced breast MRI.
- Lesion not included in the field of view of either pre- or post-NAT MRI or CEM
- Presence of pacemakers or automated implantable cardioverter defibrilator
- Pregnant women
Key Trial Info
Start Date :
August 3 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 26 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05990478
Start Date
August 3 2023
End Date
July 26 2024
Last Update
May 21 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.